Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07804576 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessment of Lung Function (Lufu) at Sea Level LA vs. High Altitude HA in Patients With Pulmonary Arterial Hypertension PAH

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 4, 2026 (before its estimated October 4, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
To study the effect of a re-ascent to high altitude (Quito Ecuador: 2850m) after a one-week stay at sea level (after prior descent from 2850m) on lung function and pulmonary resistance/reactance in patients with pulmonary arterial disease PAH, who live permanently \> 2600m.
Trial Details
NCT Number NCT07804576
Lead Sponsor Silvia Ulrich Somaini
Conditions
(from sponsor)		 Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease, High Altitude Effects, High Altitude, Lung Function Testing, Lung Function Changes
Related terms Altitude Sickness, Pulmonary Arterial Hypertension
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov